Brief: Diaceutics Says H1 2026 Revenue Grows 22% At Constant Currency To £17.50 Million
29/07/2026 07:29
BRIEF-Diaceutics Says H1 2026 Revenue Grows 22% At Constant Currency To £17.50 Million July 29 (Reuters) - Diaceutics PLC DXRX.L:
DIACEUTICS - H1 2026 REVENUE GROWS 22% AT CONSTANT CURRENCY TO £17.50 MILLION
DIACEUTICS - H1 2026 GROSS MARGIN EXPECTED AT 87% AND ADJUSTED EBITDA AT £1.10 MILLION
DIACEUTICS PLC: AI IS BEING EMBEDDED ACROSS DXRX PLATFORM AND OPERATING MODEL TO ENHANCE CUSTOMER INSIGHTS, IMPROVE PRODUCTIVITY
DIACEUTICS PLC: TARGETS FOR 2026 ARE ON TRACK
Source text: ID:nRSc2441Oa
Further company coverage: DXRX.L